fda regulations on semaglutide new for alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products These highlights do not include – Safe use of compounded GLP

To put it simply, if a GLP-1 or triple G-agonist even got rid of insulin requirement in 1 out of 10 new onset Type 1 diabetics, that would be a very big deal

Diabetes and cognitive dysfunction

Healthcare providers may avoid prescribing topiramate for individuals with a history of: Suicidal thoughts or behaviors Kidney stones Metabolic acidosis Bone conditions like osteopenia, osteomalacia, or osteoporosis Glaucoma Respiratory issues like asthma or COPD Depression or mood disorders Growth problems Thyroid, liver, or kidney disease Because topiramate can increase the risk of kidney stones, its important to stay well-hydrated while taking the medication

(2023) covered additional pharmacokinetic profiles

Consult your doctor or a weight loss specialist for personalized advice.